nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—CREB1—Signaling events regulated by Ret tyrosine kinase—PDLIM7—pharynx cancer	0.0706	0.144	CbGpPWpGaD
Naloxone—CREB1—mouth—pharynx cancer	0.055	0.108	CbGeAlD
Naloxone—CREB1—neck—pharynx cancer	0.047	0.0926	CbGeAlD
Naloxone—CREB1—saliva-secreting gland—pharynx cancer	0.0367	0.0722	CbGeAlD
Naloxone—CREB1—brainstem—pharynx cancer	0.0359	0.0707	CbGeAlD
Naloxone—CREB1—epithelium—pharynx cancer	0.032	0.063	CbGeAlD
Naloxone—TLR4—lymph node—pharynx cancer	0.0316	0.0622	CbGeAlD
Naloxone—CREB1—lymphoid tissue—pharynx cancer	0.0247	0.0485	CbGeAlD
Naloxone—CREB1—spinal cord—pharynx cancer	0.0223	0.044	CbGeAlD
Naloxone—TLR4—Pathogenic Escherichia coli infection—CDH1—pharynx cancer	0.0215	0.0438	CbGpPWpGaD
Naloxone—CREB1—head—pharynx cancer	0.0199	0.0391	CbGeAlD
Naloxone—OPRM1—brainstem—pharynx cancer	0.0194	0.0381	CbGeAlD
Naloxone—ESR1—neck—pharynx cancer	0.0185	0.0364	CbGeAlD
Naloxone—CYP3A4—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0169	0.0343	CbGpPWpGaD
Naloxone—CREB1—miRNAs involved in DNA damage response—CCND1—pharynx cancer	0.0158	0.0322	CbGpPWpGaD
Naloxone—OPRD1—head—pharynx cancer	0.0157	0.0309	CbGeAlD
Naloxone—OPRK1—head—pharynx cancer	0.0151	0.0296	CbGeAlD
Naloxone—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0148	0.03	CbGpPWpGaD
Naloxone—ESR1—brainstem—pharynx cancer	0.0141	0.0278	CbGeAlD
Naloxone—CREB1—lymph node—pharynx cancer	0.0139	0.0274	CbGeAlD
Naloxone—ESR1—epithelium—pharynx cancer	0.0126	0.0248	CbGeAlD
Naloxone—OPRM1—spinal cord—pharynx cancer	0.012	0.0237	CbGeAlD
Naloxone—OPRM1—head—pharynx cancer	0.0107	0.0211	CbGeAlD
Naloxone—CREB1—miRNAs involved in DNA damage response—TP53—pharynx cancer	0.0104	0.0212	CbGpPWpGaD
Naloxone—SLCO1A2—spinal cord—pharynx cancer	0.0104	0.0204	CbGeAlD
Naloxone—ESR1—lymphoid tissue—pharynx cancer	0.0097	0.0191	CbGeAlD
Naloxone—SLCO1A2—head—pharynx cancer	0.00922	0.0181	CbGeAlD
Naloxone—CYP2C8—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00884	0.018	CbGpPWpGaD
Naloxone—TLR4—Spinal Cord Injury—CCND1—pharynx cancer	0.00872	0.0177	CbGpPWpGaD
Naloxone—CREB1—B Cell Receptor Signaling Pathway—CD79A—pharynx cancer	0.00857	0.0174	CbGpPWpGaD
Naloxone—CREB1—Trk receptor signaling mediated by PI3K and PLC-gamma—CCND1—pharynx cancer	0.00787	0.016	CbGpPWpGaD
Naloxone—ESR1—head—pharynx cancer	0.00782	0.0154	CbGeAlD
Naloxone—CYP2C8—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00775	0.0158	CbGpPWpGaD
Naloxone—TLR4—Spinal Cord Injury—EGFR—pharynx cancer	0.00684	0.0139	CbGpPWpGaD
Naloxone—CREB1—Integrin-linked kinase signaling—CCND1—pharynx cancer	0.00658	0.0134	CbGpPWpGaD
Naloxone—ALB—lymph node—pharynx cancer	0.00642	0.0126	CbGeAlD
Naloxone—CREB1—EGFR interacts with phospholipase C-gamma—EGFR—pharynx cancer	0.00631	0.0128	CbGpPWpGaD
Naloxone—CREB1—PLCG1 events in ERBB2 signaling—EGFR—pharynx cancer	0.00617	0.0125	CbGpPWpGaD
Naloxone—TLR4—Spinal Cord Injury—TP53—pharynx cancer	0.00574	0.0117	CbGpPWpGaD
Naloxone—ESR1—lymph node—pharynx cancer	0.00548	0.0108	CbGeAlD
Naloxone—CREB1—Signaling mediated by p38-alpha and p38-beta—TP53—pharynx cancer	0.0053	0.0108	CbGpPWpGaD
Naloxone—CREB1—ATF-2 transcription factor network—CCND1—pharynx cancer	0.0053	0.0108	CbGpPWpGaD
Naloxone—CYP2C8—Biological oxidations—CNDP2—pharynx cancer	0.00519	0.0106	CbGpPWpGaD
Naloxone—CREB1—Validated targets of C-MYC transcriptional repression—CCND1—pharynx cancer	0.00503	0.0102	CbGpPWpGaD
Naloxone—ABCB1—epithelium—pharynx cancer	0.00498	0.00979	CbGeAlD
Naloxone—CREB1—B Cell Activation—CD79A—pharynx cancer	0.0049	0.00997	CbGpPWpGaD
Naloxone—CREB1—ATM Signaling Pathway—TP53—pharynx cancer	0.00476	0.00968	CbGpPWpGaD
Naloxone—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00475	0.00965	CbGpPWpGaD
Naloxone—CREB1—DNA Damage Response—CCND1—pharynx cancer	0.00473	0.00962	CbGpPWpGaD
Naloxone—CREB1—G1 to S cell cycle control—CCND1—pharynx cancer	0.00473	0.00962	CbGpPWpGaD
Naloxone—CYP2C8—Biological oxidations—ADH7—pharynx cancer	0.0047	0.00955	CbGpPWpGaD
Naloxone—CREB1—AP-1 transcription factor network—CCND1—pharynx cancer	0.00462	0.0094	CbGpPWpGaD
Naloxone—CREB1—miRNA Regulation of DNA Damage Response—CCND1—pharynx cancer	0.00457	0.00929	CbGpPWpGaD
Naloxone—ESR1—FOXM1 transcription factor network—CCND1—pharynx cancer	0.00456	0.00926	CbGpPWpGaD
Naloxone—CREB1—LKB1 signaling events—TP53—pharynx cancer	0.0045	0.00914	CbGpPWpGaD
Naloxone—ABCB1—trachea—pharynx cancer	0.0044	0.00866	CbGeAlD
Naloxone—CREB1—Leptin signaling pathway—CCND1—pharynx cancer	0.00437	0.00889	CbGpPWpGaD
Naloxone—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00416	0.00846	CbGpPWpGaD
Naloxone—CYP2C8—Biological oxidations—ADH1B—pharynx cancer	0.00412	0.00837	CbGpPWpGaD
Naloxone—ABCB1—lymphoid tissue—pharynx cancer	0.00383	0.00754	CbGeAlD
Naloxone—CREB1—Androgen receptor signaling pathway—CCND1—pharynx cancer	0.00381	0.00775	CbGpPWpGaD
Naloxone—ABCB1—spinal cord—pharynx cancer	0.00347	0.00684	CbGeAlD
Naloxone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—pharynx cancer	0.00347	0.00706	CbGpPWpGaD
Naloxone—ESR1—ATF-2 transcription factor network—CCND1—pharynx cancer	0.00347	0.00706	CbGpPWpGaD
Naloxone—TLR4—Immune System—CD79A—pharynx cancer	0.00344	0.00698	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—CDH1—pharynx cancer	0.00335	0.00682	CbGpPWpGaD
Naloxone—ESR1—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.00332	0.00676	CbGpPWpGaD
Naloxone—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—pharynx cancer	0.00325	0.00661	CbGpPWpGaD
Naloxone—CREB1—Signaling by NOTCH—CCND1—pharynx cancer	0.00324	0.00659	CbGpPWpGaD
Naloxone—CREB1—Oncostatin M Signaling Pathway—TP53—pharynx cancer	0.00323	0.00657	CbGpPWpGaD
Naloxone—CREB1—DNA Damage Response—TP53—pharynx cancer	0.00312	0.00633	CbGpPWpGaD
Naloxone—CREB1—G1 to S cell cycle control—TP53—pharynx cancer	0.00312	0.00633	CbGpPWpGaD
Naloxone—ESR1—Regulation of Telomerase—CCND1—pharynx cancer	0.0031	0.0063	CbGpPWpGaD
Naloxone—ABCB1—head—pharynx cancer	0.00309	0.00608	CbGeAlD
Naloxone—CREB1—Constitutive PI3K/AKT Signaling in Cancer—EGFR—pharynx cancer	0.00308	0.00625	CbGpPWpGaD
Naloxone—CREB1—AP-1 transcription factor network—TP53—pharynx cancer	0.00304	0.00619	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—CCND1—pharynx cancer	0.00303	0.00615	CbGpPWpGaD
Naloxone—CREB1—miRNA Regulation of DNA Damage Response—TP53—pharynx cancer	0.00301	0.00612	CbGpPWpGaD
Naloxone—CREB1—Androgen receptor signaling pathway—EGFR—pharynx cancer	0.00299	0.00608	CbGpPWpGaD
Naloxone—ESR1—LKB1 signaling events—TP53—pharynx cancer	0.00294	0.00599	CbGpPWpGaD
Naloxone—ESR1—Leptin signaling pathway—CCND1—pharynx cancer	0.00286	0.00582	CbGpPWpGaD
Naloxone—CYP3A4—Biological oxidations—CNDP2—pharynx cancer	0.00279	0.00567	CbGpPWpGaD
Naloxone—CREB1—PI-3K cascade—EGFR—pharynx cancer	0.00277	0.00563	CbGpPWpGaD
Naloxone—CREB1—PI3K/AKT activation—EGFR—pharynx cancer	0.0027	0.0055	CbGpPWpGaD
Naloxone—CREB1—GAB1 signalosome—EGFR—pharynx cancer	0.00268	0.00545	CbGpPWpGaD
Naloxone—CREB1—Glucocorticoid receptor regulatory network—TP53—pharynx cancer	0.00268	0.00545	CbGpPWpGaD
Naloxone—CREB1—ErbB1 downstream signaling—EGFR—pharynx cancer	0.00262	0.00533	CbGpPWpGaD
Naloxone—CREB1—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—pharynx cancer	0.00262	0.00533	CbGpPWpGaD
Naloxone—CYP3A4—Biological oxidations—ADH7—pharynx cancer	0.00252	0.00513	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—CCND1—pharynx cancer	0.0025	0.00508	CbGpPWpGaD
Naloxone—ESR1—Regulation of Telomerase—EGFR—pharynx cancer	0.00243	0.00494	CbGpPWpGaD
Naloxone—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	0.00221	0.00449	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—CDH1—pharynx cancer	0.0022	0.00446	CbGpPWpGaD
Naloxone—ABCB1—lymph node—pharynx cancer	0.00216	0.00426	CbGeAlD
Naloxone—CREB1—Signaling by NOTCH—TP53—pharynx cancer	0.00214	0.00434	CbGpPWpGaD
Naloxone—CREB1—Signaling by SCF-KIT—EGFR—pharynx cancer	0.00207	0.00421	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.00207	0.00421	CbGpPWpGaD
Naloxone—CREB1—Disease—B4GALT5—pharynx cancer	0.00202	0.00411	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—TP53—pharynx cancer	0.00199	0.00405	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.00198	0.00403	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CD79A—pharynx cancer	0.00198	0.00402	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—EGFR—pharynx cancer	0.00196	0.00399	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB4—EGFR—pharynx cancer	0.00195	0.00396	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—EGFR—pharynx cancer	0.00192	0.00391	CbGpPWpGaD
Naloxone—TLR4—Immune System—CDH1—pharynx cancer	0.00191	0.00389	CbGpPWpGaD
Naloxone—CREB1—Downstream signal transduction—EGFR—pharynx cancer	0.00186	0.00379	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR—EGFR—pharynx cancer	0.00185	0.00377	CbGpPWpGaD
Naloxone—CREB1—EGF/EGFR Signaling Pathway—EGFR—pharynx cancer	0.00185	0.00377	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB2—EGFR—pharynx cancer	0.00184	0.00375	CbGpPWpGaD
Naloxone—CREB1—DAP12 signaling—EGFR—pharynx cancer	0.00183	0.00373	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	0.00181	0.00368	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—CNDP2—pharynx cancer	0.00181	0.00368	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR in disease—EGFR—pharynx cancer	0.00173	0.00351	CbGpPWpGaD
Naloxone—CREB1—DAP12 interactions—EGFR—pharynx cancer	0.00173	0.00351	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.00173	0.00351	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR—EGFR—pharynx cancer	0.00171	0.00348	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.0017	0.00345	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—EGFR—pharynx cancer	0.00169	0.00343	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—TP53—pharynx cancer	0.00165	0.00335	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—CCND1—pharynx cancer	0.00164	0.00333	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—ADH7—pharynx cancer	0.00163	0.00332	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.00162	0.0033	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—EGFR—pharynx cancer	0.0016	0.00325	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.00153	0.00311	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pharynx cancer	0.00148	0.003	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—ADH1B—pharynx cancer	0.00143	0.00291	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—B4GALT5—pharynx cancer	0.00137	0.00279	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.00136	0.00277	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.00136	0.00276	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—TP53—pharynx cancer	0.00131	0.00266	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—EGFR—pharynx cancer	0.00128	0.00261	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—EGFR—pharynx cancer	0.00128	0.0026	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—TP53—pharynx cancer	0.00126	0.00257	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD79A—pharynx cancer	0.0012	0.00244	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—EGFR—pharynx cancer	0.00118	0.00239	CbGpPWpGaD
Naloxone—TLR4—Immune System—EGFR—pharynx cancer	0.00112	0.00228	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CDH1—pharynx cancer	0.0011	0.00224	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—TP53—pharynx cancer	0.00108	0.00219	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—EGFR—pharynx cancer	0.00106	0.00216	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.00106	0.00216	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000893	0.00182	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CNDP2—pharynx cancer	0.000888	0.00181	CbGpPWpGaD
Naloxone—ALB—Metabolism—CNDP2—pharynx cancer	0.000883	0.0018	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ADH7—pharynx cancer	0.000803	0.00163	CbGpPWpGaD
Naloxone—ALB—Metabolism—ADH7—pharynx cancer	0.000799	0.00162	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CNDP2—pharynx cancer	0.000774	0.00157	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—EGFR—pharynx cancer	0.00076	0.00154	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000718	0.00146	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ADH1B—pharynx cancer	0.000704	0.00143	CbGpPWpGaD
Naloxone—ALB—Metabolism—ADH1B—pharynx cancer	0.0007	0.00142	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ADH7—pharynx cancer	0.0007	0.00142	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—B4GALT5—pharynx cancer	0.000673	0.00137	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—EGFR—pharynx cancer	0.000671	0.00136	CbGpPWpGaD
Naloxone—ALB—Metabolism—B4GALT5—pharynx cancer	0.000669	0.00136	CbGpPWpGaD
Naloxone—CREB1—Immune System—CDH1—pharynx cancer	0.000668	0.00136	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—EGFR—pharynx cancer	0.000644	0.00131	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ADH1B—pharynx cancer	0.000614	0.00125	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—B4GALT5—pharynx cancer	0.000586	0.00119	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000563	0.00114	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.000477	0.000969	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000473	0.000961	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ADH7—pharynx cancer	0.000431	0.000877	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—EGFR—pharynx cancer	0.000428	0.000869	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—EGFR—pharynx cancer	0.000426	0.000867	CbGpPWpGaD
Naloxone—CREB1—Immune System—EGFR—pharynx cancer	0.000391	0.000794	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ADH1B—pharynx cancer	0.000378	0.000769	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—EGFR—pharynx cancer	0.000374	0.00076	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—B4GALT5—pharynx cancer	0.000361	0.000735	CbGpPWpGaD
Naloxone—CREB1—Disease—EGFR—pharynx cancer	0.000361	0.000733	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CCND1—pharynx cancer	0.000322	0.000655	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CCND1—pharynx cancer	0.000321	0.000652	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—EGFR—pharynx cancer	0.000316	0.000642	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CCND1—pharynx cancer	0.000281	0.000572	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—EGFR—pharynx cancer	0.000253	0.000514	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—EGFR—pharynx cancer	0.000252	0.000512	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TP53—pharynx cancer	0.000247	0.000503	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CCND1—pharynx cancer	0.000238	0.000484	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—EGFR—pharynx cancer	0.000221	0.000449	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TP53—pharynx cancer	0.000212	0.000431	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TP53—pharynx cancer	0.000211	0.00043	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CCND1—pharynx cancer	0.000211	0.000429	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—EGFR—pharynx cancer	0.000187	0.000379	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TP53—pharynx cancer	0.000185	0.000377	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—EGFR—pharynx cancer	0.000165	0.000336	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TP53—pharynx cancer	0.000157	0.000319	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TP53—pharynx cancer	0.000139	0.000282	CbGpPWpGaD
